Reddit Posts
Any advice on what to YOLO on this week?
How I am Positioning myself in the Markets going into 2024
Does FSR really look like a buy or YOLO?
What's a better long term buy now. BMY vs. PFE?
Seeking suggestions on companies to swap DIS, PFE and BMY with in year end tax loss harvesting
$RNXT $1.00 +25.63% #Cancer #Treatment #Research
$PFE Pfizer down 8% since Cramer’s buy call 12 days ago
What stocks are under additional pressure in December due to tax loss harvesting?
Cramer shuffling papers this morning over $PFE
@PFE Pfeizer 5.5% Yield with January Effect and Weight loss pill testing
Why wouldn't you invest a large amount of money into Pfizer right now and ride it out for a few years?
Long time investment, estimated rocketing by 2025 [CYBN]
7 Diabetes and Weight Loss Drug Stocks With Big Potential
$RGBP Must read mRNA #FDA in play!
Down 11% on taxable account. Planning on buying a house in the next 2.5-3 years. Should I sell or change strategies?
I told you so 5 months ago - NO RECESSION NO PIVOT
BNOX - Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
$NRXS IBS treatment with less side effects than their competitors
CDC: New Variant BA.2.86 More Capable of Causing Infection In Those Previously Vaccinated or Infected
Bull Case Through EOY : Pfizer ($PFE)
WSJ: Pfizer’s Covid Boost Crashes to Earth. "Shares are down 31% YTD, a loss of more than $88 billion in market capitalization"
Post-COVID Era Plays (Lessons from $PFE earnings)
what does it mean if a company has over 100% institutional ownership
Bull Thesis for Dr Reddy’s Laboratories (NYSE: RDY)
$SGEN spread at 15% now looking like steal of a Merger play
What to do for Pfizer's Earnings tomorrow morning
Why I'm not playing LOGI Earnings Tonight
Stocks could soar in the 'return to work from home' play as BNTX vaccine shown to be 4% effective vs circulating XBB Variant in new study
Stocks Set To Soar As Bivalent Vaccine Found 4% Effective Vs XBB Covid Variant
Johnson & Johnson Earnings Are Here: Should You Buy?
Tiziana Life Sciences $TLSA is Bracing for an Explosive 2023
The Catalysts Behind Tiziana Life Sciences' (NASDAQ: TLSA) 70%
Mirati | Investors are to Fight Losses from $MRTX downfall.
Pfizer, Astellas avoid forced price reduction for cancer drug Xtandi (NYSE:PFE)
Pfizer CEO pockets $33M for 2022 after 36% pay hike (NYSE:PFE)
AbbVie, Gilead, Seagen fined for raising prices faster than inflation (NYSE:PFE)
Pfizer faces resistance in plans to modify EU COVID vaccine deal (NYSE:PFE)
Pfizer COVID pill effective on Omicron; not linked to disease rebound – FDA (NYSE:PFE)
Pfizer deal to acquire Seagen sends cancer drug maker's shares 18% higher (NYSE:PFE)
Biosimilars expected to save $180B over next five years as more gain approval (NYSE:PFE)
Pfizer, GSK gearing up for RSV vaccine rollouts this year (NYSE:PFE)
U.K. announces spring COVID booster program for at-risk individuals (NYSE:PFE)
Biden to announce plan to keep Medicare solvent beyond 2050 (NYSE:PFE)
Flu and COVID combo shots unlikely this year, FDA’s top vaccine official says (NYSE:PFE)
FBI Director says novel coronavirus likely originated from China lab leak (NYSE:PFE)
$AIM Try to name another bio stock in trials with $BMY $MRK $AZN and PFE.
Hot Stocks: SGEN climbs on takeover interest; PFE sets 52-week low; TGNA drops; KOS rises
Pharma companies dominate list of innovation leaders thanks to patents (NYSE:PFE)
Pfizer(PFE): Says Pipeline Of Drugs Will Ease Transition From COVID.
Pfizer to face FDA AdCom meeting for full approval of COVID-19 pill (NYSE:PFE)
Completed head and shoulders on PFE? Time to short?
Pfizer, BioNTech start trial for first mRNA-based shingles vaccine (NYSE:PFE)
Medicare mulls rebates in 2025 for drug prices rising faster than inflation (NYSE:PFE)
Pfizer/BioNTech, EU in talks to cut COVID vaccine deliveries for higher prices (NYSE:PFE)
PFE stock falls as Pfizer downgraded at UBS on COVID worries (NYSE:PFE)
Omicron boosters protect against new COVID strains up to three months - CDC (NYSE:PFE)
FDA plans an annual schedule for updated COVID shots (NYSE:PFE)
2023-01-16 Wrinkle-brain Plays (Mathematically derived options plays)
2023-01-16 Wrinkle-brain Plays (Mathematically derived options plays) DD
Pfizer, AbbVie, GSK, Eli Lilly among drugmakers to raise prices (NYSE:PFE)
Thoughts on shorting MRNA and PFE
Mentions
I searched the comments for PFE and didn't find anything. How many times are you going to see me say something about PFE, look at the chart and see day after day after day of green, and not pick some up? That mRNA technology they went full port on during the vid is a technology that has many applications. The chief scientific officer is a major shareholder, it's like he knows gene targeting has a lucrative and underpriced future.
PFE/Pfizer TA/momentum: looking good FA/yield/earnings: looking good analyst expectations: looking good outperformance vs analyst expectations: looking good price: still far down from trend and with lots of upside potential
Another day that PFE has beaten the s&p 500. I'm up around 11% with PFE from holding it from the $26 area. My portfolio is finally slowly coming back up after a bad couple of years due to bad timing with leverage ETFs, meme stocks and whatnot. I now have decided that I will never buy meme stocks and nor will I buy leveraged ETFs unless a 2008 situation comes along where the indexes fall a lot.
PFE has a 5 year average P/E of 13.47 (according to morningstar). It might be better to use the company average as opposed to the market average when looking at a particular name. So $40 might be a decent price target.
PFE easy money if youre into long term investing.
Observation: Pfizer (PFE) consensus estimates for earnings: 2025: $2.78 2026: $2.86 SP500 P/E average: 26x. Multiply: price = P/E x earnings = ? Bonus: they usually beat analyst estimates.
Pfizer (PFE) consensus estimates for earnings: 2025: $2.78 2026: $2.86 SP500 P/E average: 26x. Multiply price x earnings = ?
Feel like PFE puts are a good idea right about now. Also apple puts.
I've held PFE for a while. It has a very hard time keeping its gains on days like this. I would sell.
PFE up over 12% in the last 15 days now. Lets go
PFE is breaking out of resistance ![img](emote|t5_2th52|4276)
https://stockcharts.com/sc3/ui/?s=PFE Note the green and blue moving averages (20, 50)
Come on PFE. Just need 30$ this week
PFE is the best investment you won't make today. JB says 'under 30 it's a gift'.
Hey how about we all buy PFE now! Just for funnsie 🤭
https://stockcharts.com/sc3/ui/?s=PFE Note the green and blue moving averages (20, 50)
https://stockcharts.com/sc3/ui/?s=PFE Note the green and blue moving averages (20, 50)
>Dividends from quality companies like Pepsi, Microsoft, Waste Management, etc.. are NOT "fools' gold". These are quality companies that have a long history of paying and increasing dividends every year. >**Pepsi** = 51 years of dividend payment and dividend growth >**Microsoft** = 19 years of dividend payment and dividend growth >**Waste Management** = 20 years of dividend payment and dividend growth Now let's look at a few other Dividend Aristocrats over the years: * **Walgreens** (WBA) = 47 years of dividend payment and dividend growth, until January 2024 * **AT&T** (T) = 36 years of dividend payment and dividend growth, until 2021 * **Pitney Bowes** (PBI) = 31 years of dividend payment and dividend growth, until 2013 * **Eli Lilly** (LLY) = 43 years of dividend payment and dividend growth, until 2010 * **General Electric** (GE) = 32 years of dividend payment and dividend growth, until 2009 * **Pfizer** (PFE) = 41 years of dividend payment and dividend growth, until 2009 * **KeyCorp** (KEY) = 43 years of dividend payment and dividend growth, until 2009 * **Avery Dennison** (AVY) = 32 years of dividend payment and dividend growth, until 2009 * **U.S. Bancorp** (USB) = 36 years of dividend payment and dividend growth, until 2008 Then there's Kodak, Polaroid, General Motors... the list of fallen Dividend Aristocrats is longer than the list of current ones. Survivor bias is a foundation of sand on which to build a retirement portfolio.
Long PFE y'all!! I am all in. With their current pipeline growing at around 8-10% a year and with cancer ramping up, this is a no-brainer. This will be at least 30-31 EOY. Everyone should hold a position in this
I also just started DCAing into PFE. I think anything under 30 is a steal if you can hold for a few years.
I just got into PFE with 100 stocks. It’s also my first investment ever. I think it has great potential, their dividend is consistently good and I believe I got in at the bottom.
Does anyone here hold PayPal? I am currently all in PFE average $26 but want to allocate 20% into PayPal at these levels. They currently are buying back shares at around 8% float and are growing every year and I don't see them going away.
PFE has a quarterly dividend coming up, $0.42/share ($1.68 annually), payable on June 14, 2024. The ex-dividend date for that dividend payment was 5/9. In order to qualify to receive the dividend, the shares must be owned before the ex-dividend date. The ex-dividend date is typically set two days before the record date, which is when the company determines who its shareholders of record are / who is entitled to receive the dividend. The extrinsic value remaining on the PFE $27 call with 5/17 expiration (about 0.11) is far less than the $0.42/share upcoming dividend. A holder of that option would have been incentivized to exercise the option early, by 5/8 at the latest, to qualify to receive the dividend. Upcoming dividend payments are something to be mindful of when writing options, because they're one of a short list of straightforward reasons why our short options may get exercised early.
Well concentration builds wealth, diversification protects wealth. I am trying to build wealth here plus I believe in PFE.
It's only going up from here buddy. I am all in on PFE. My average cost is around $26
Back to 27 dollars, PFE can’t sustain share price appreciation lol
PFE is a cutting edge high-tech drug company out of the Midwest awaiting imminent patent approval on the next generation of cancer fighting drugs and mRNA vaccines that have both huge government and civilian applications now.
Copy pasta from ~ 3:30 Added 519c for friday: @ 0.89 HL 5c for 5/17 @ 0.15 (break even is silly) Order in for RVMD 40c 5/17 @ 1.55 (won't fill, but they are bedmates with AMGN) PFE 29c out to 6/21 may make something. NOT married to them LLY, crazy diamond, you. Still Battleship-Gold-Bonding those with my geriatric ass PACK... you stink. Out to 11/15, 7.5c. If it would just do the thing. KTOS STILL languishes there like a [redacted] in Las Vegas August heat. Monkey business. OH... the FD ARM too.
100k on PFE calls when their was rumour of a new variant, I bought calls and 3 days later the world health organization talks about it and everything goes crazy
> Coupon is fixed, but the yield floats with the ten year treasury yield plus a small risk premium. I think that's what I also said - prefs are more similar to bonds than to stock dividends. Every word in that sentence applies just as much to bonds as to prefs. > PFE still has a covid hangover unfortunately. They've written covid-related revenue down practically to zero, in fact, it went VERY negative last year because the US govt shipped back paxlovid doses to be repurchased later. Covid stuff hardly featured in the recent earnings. > Good luck tho. Ty.
Coupon is fixed, but the yield floats inversely with the ten year treasury yield plus a small risk premium. PFE still has a covid hangover unfortunately. Good luck tho.
I think the time has changed and that PFE will give good returns moving forward due to many reasons like: Bullish: 1. PFE non-Covid pipeline launches and products showed 10% operational growth Y/Y with 11% in this years earning report excluding COVID products. 2023 revenue was higher than pre COVID reveneue 2. PFE reported selling stakes in haleon to pay for current debt and they are currently deleveraging and might start doing buybacks as early as next year 3. Fast Track Phase 2 - Covid 19 + Influenza Vaccine that MAY allow it to tap into the annual flu shot market instead of completely wasting Covid vaccine inventories 4. SEAGEN acquisition: 33% Y/Y revenue growth from SEAGEN net product sales, Q/Q revenue growth at ~27.11% with $648m for Q3 2023 vs $510m Q3 2022. Q1 2024 sales were 742 million. Also global cancer rates are set to increase 77% by 2050, the WHO warns which is good for PFE 5. For 2024, Pfizer expects adjusted earnings of $2.15 to $2.35 per share and $58.5 billion to $61.5 billion in sales. At the midpoints, earnings would climb more than 22% as sales rise almost 3%.
PFE is not a great play nor a bad one, it’s a unknown: 1) no GLP-1 so far 2) SGEN unproven 3) huge debt burden to finance SGEN 4) huge payout ratio
I believe in you. And by you I mean PFE still being undervalued and only having 1/6 red days with a couple days to go for your bet.
Cramer plugged PFE. What a dick.
This is a good entry point for PFE. Patient dying from gene therapy trial has made the stock go down by over 2% and this is basically an overreaction and just ex divy games being played out by them. Less people holding = less money paid out via divy which means money saved for Pfizer. This is actually bullish lol.
>Pfizer, $PFE, has paused a study of an experimental gene therapy for muscular dystrophy after a child who received it died suddenly, per Bloomberg >
What was that rug pull on PFE all about today?
PFE straight vertical dive down lol. Lost 1.7% in 10 mins
PFE and INTC are thee worst...
PFE is undervalued. Dividend coming up, people be buying.
PFE to the motherf%*king moon.
Next time, buy only dividend-paying stocks? and wait a very long time? PFE, BMY, JNJ, SBUX, SCHD Etf, blah blah blah blah, ... sorry for your losses!
Sold PFE calls for near 100% profit, but I might still get banned lol
PFE flying recently. Is this legit or another dead cat bounce as before ?
PFE has been my golden child the past week
Looking at share price in a vacuum is not that useful. PFE is approximately the 80th most valuable company in the world, with a market cap of $157.5B. Market cap is the measures of the total value of a company and is measured as: Current Price per Share * Total Number of Outstanding Shares. PFE is sitting near 52-week lows at $27.81, because it has seen better times. Following a big run-up in the company's value during the height of Covid, it continues to lose the revenue benefits of its Covid drugs. Per Q1 Earnings, earnings per share (EPS) decline 33% year over year, with revenue of -20% for Q1 2024 vs. Q1 2023. Those earnings technically 'beat' analyst estimates, but those were greatly revised/lowered estimates, reflecting limited good sentiment for PFE. Better times/a higher valuation (and stock price) could be in PFE's future, but the market does not see fit to price that into the stock at the moment. The Seagen acquisition could ultimately prove to be dynamic and successful, but drug research and development is an expensive and often unfruitful undertaking. The market is therefore in "wait and see" mode re: PFE.
they probably are undervalued but in my own dd they have one of the largest criminal fines in history, covid 19 sales very low, of all the drug companies i know follow im least interested in their pipeline. I wouldnt mind holding some PFE common stock but id perfer to purchase at closer to 20 a share first.
You should stop scalping or trading options. Save every month and invest in solid, dividend-paying, oversold stocks. Take a close look at PFE INTC BMY KHC CVS SBUX Nestle Swatch, Louis Vuitton, Dior, Kering, etc. Do you like risk? Buy more TSLA and BTC. Sorry, but there's no magic formula for getting rich quick. It's almost impossible.
I've been eyeing PFE for a month. I agree that there has been an overreaction but I'm not sure there's anything in their pipeline to make the stock move.
For anyone who has been paying attention, what is your opinion on Pfizer (PFE) price for the next couple of weeks? I am rather confident in its ability to reach near 30 dollars/share or above in the near future. I believe it’s been a large overreaction by the market to make the stock reach decade lows recently.
Why was there such a huge colume of PFE being bought in the last 10 minutes?
PFE is on da move ![img](emote|t5_2th52|4276)
I was shilling PFE a month ago, and ppl called me a boomer 😂
We’re trending! PFE gang!
Shamelessly plugging PFE for another day. Its potential is undervalued and the price is still low. Chief scientific officer is going to fill the pipeline with successful mRNA treatments/ preventatives. Source: my wife.
i have abbv and i literally don’t like it. it’s dead water. i have like 30% gain in it. i would rather add on to PFE than abbv, which I did. All my recent add ons are value stocks. looks to me market is rotating to value including chinese stocks , which makes sense. I added energy and mag 7 tech mutual funds. tech neeeds a good rest to advance, especially AI stocks.
Exdividen date on the 9th PFE could continue higher
I only own 180 shares of PFE
Looks like Josh Brown doubled down on PFE.
Like I tried to do it as random as possible with buying options on PINS, SNAP and PFE right before their earnings and I made a shit ton of profit on all of it, but then the only trade I’m 100% sure and that I’ve done research on etc, I lose -98,0% while it has been having great earnings since George Washington has been 6ft underground?
CVS is trading around 10x TTM earnings, which is about normal for it. It's hard to argue a discount based on that. They also had a big earnings fall off last quarter. If you think that's temporary, it's probably a good buy. If you think kits a bigger problem, probably not. PFE has some patent cliff issues. Again, it's not that far off it's historical valuations at this point, so again, if you think it will perform well in the future despite what the market thinks, then it's a buy. SBUX....I actually find the most interesting personally. It's always been a really strong company. I'd want to know more about why they took a hit last quarter. If it's transient, I think it's a great pickup. If not, maybe they have problems. A lot of other restaurants are having earnings issues too. If this is a societal change, it's bad for Starbucks. If it's a blip.... buying opportunity.
> Any reason for long term (20+ years) not to buy these dips on CVS, SBUX, PFE? PFE is not well managed but probably got to the point of being overhated, CVS could easily go nowhere much for years. CVS is in a better situation than WBA but that's not saying much. SBUX is okay but not without concerns. I'd say at least 2/3 of these names turn out to be and/or continue to be value traps. Also, a lot of people talk about being "long-term" then get increasingly frustrated when 6-12-18 months go by and the name in question is underperforming while they see other things ramping higher.
* CVS - could go the way of WBA * SBUX - there challenges are real and go beyond expensive lattes. I'm not sure they are unsolvable but management needs to demonstrate they have a good plan that is working. They can't just blame weak consumers when competitors are taking market share. * PFE - weightloss and pipeline is not a guaranteed slam dunk. You could certainly argue that they are priced for all the risks but just want to point out there are reasons.
PFE is not a good deal imo. Once they discontinue Danuglipron, it will go back to 25
PFE is a good deal right now. Starbucks is still overvalued. CVS is an ok deal right now but I would wait till it goes down a bit farther
PFE up 2% after a 6% earnings rise yesterday. Lets go
Any reason for long term (20+ years) not to buy these dips on CVS, SBUX, PFE? I get they could still go down in the near future but they all seem like solid discounts
https://finviz.com/map.ashx?t=sec Strange to see - QCOM outperforming tech - PFE outperforming healthcare - BA outperforming aerospace - AIG outperforming financials
Anyone have suggestions for a couple of good stocks outside of tech to ride out the next year or two? I think I’m currently too tech heavy—MSFT, GOOG, TSM, ZS, and (tech heavy) SPY. Only have PFE (healthcare) and PVH (retail apparel) outside of tech. I want to avoid energy except maybe wind. I keep seeing that financial sector has lots of potential but difficult to assess which positions might be best there.
PFE could go up another 10% and still be worth less than it was before 2020. The potential of their cancer pipeline is undervalued and the stock has been punished too much for it's 2020 activities. I watched it go from 60% to nearly 70% institutional ownership in recent months and I think the 67% institutional ownership will hold while 33% of the float influences price movement.
Who knew PFE would be my winner this week?
I haven't added shares for the same reason I didn't invest in LLY 5 years ago, I don't understand the business anywhere near well enough. How do I know I'm not investing into PFE in the late 90s, on the back of incredible stock returns, only to get a stock that went nowhere for 25 years?
Been in YINN for months now. Staring to pay off but it’s more of a hedge against US economy and my other holdings. This not a high conviction pick. More of a speculation on the deep valuation cuts. PFE and BNTX are new additions that I trust more.
Looks like a rotation into beat up health care today. JNJ PFE HUM.
DASH puts, PFE calls
For a balanced stock portfolio PFE is a high dividend defensive industry stock at the current price. I own PFE and Nvda.
I like to just play either stocks or Buy Calls or Puts to limit only risk. Not writing calls or puts. Thing is neither fundamental- Amazon, PFE are working nir technical- SNAP, IbRx, buster working nor gut feeling working - SPY
When tech runs hot, buy the boring shit like MO and PFE that are hovering around 52 week lows
You’d be ITM.. with 2 days to go.. Would not surprise me to have a small short covering rally… folks been hating $PFE
In one of the worst months in a long time, I somehow managed to make money on every single call I bought. NKE, PENN, PARA, and PFE. Insane luck.
Sure but with PFE you're looking at max drawdown of $25 with a 6% dividend and potential for gains. Unless we get a recession, I doubt it falls much below $25.
Sure your points are valid but I think the time has changed and that PFE will give good returns moving forward due to many reasons like: Bullish: 1. PFE non-Covid pipeline launches and products showed 10% operational growth Y/Y with 11% in today's earning report excluding COVID products. 2023 revenue was higher than pre COVID reveneue 2. PFE reported selling stakes in haleon to pay for current debt and they are currently deleveraging and might start doing buybacks as early as next year 3. Fast Track Phase 2 - Covid 19 + Influenza Vaccine that MAY allow it to tap into the annual flu shot market instead of completely wasting Covid vaccine inventories 4. SEAGEN acquisition: 33% Y/Y revenue growth from SEAGEN net product sales, Q/Q revenue growth at ~27.11% with $648m for Q3 2023 vs $510m Q3 2022. Also global cancer rates are set to increase 77% by 2050, the WHO warns which is good for PFE 5. For 2024, Pfizer expects adjusted earnings of $2.15 to $2.35 per share and $58.5 billion to $61.5 billion in sales. At the midpoints, earnings would climb more than 22% as sales rise almost 3%.
Because I sold a call. And even worse, is that I got a nice premium for it, but even now after it has gone up so much, I can still buy to close the call for less than I got for it. No one has faith in PFE.